Insights
An Assessment of the Unified Patent Court’s International Jurisdiction and the Sovereign Response of Third States in Light of Recent Case Law
The scope of the international jurisdiction of the Unified Patent Court (“UPC”) has, in recent years, become one of the most striking and controversial issues in patent litigation. Having commenced its operations in 2023, the Court was established with the objective of creating a uniform and centralized patent adjudication system across Europe. However, through its recent decisions, the UPC appears not to confine its jurisdiction to Contracting Member States alone, but rather… »
Schrödinger’s Paradox in the Patent World: Can a Marketed Product Fall Outside the Prior Art?
On 2 July 2025, the Enlarged Board of Appeal of the European Patent Office (“EPO”), in its decision G 1/23, clarified whether a product already placed on the market, but whose internal structure cannot be analysed or reproduced by the skilled person, may nevertheless be excluded from the state of the art in the assessment of inventive step. In doing so, the Board added a new dimension to the ongoing debate following decision G 1/92. The dispute giving rise to the decision… »
Market Availability of Products and Parallel Trade
Counterfeit and illicitly traded health products remained a persistent concern in Türkiye throughout 2025, as reflected both in enforcement statistics and in external reporting on supply chain integrity. Despite the legal prohibition on the online sale of pharmaceutical products, there has been a noticeable increase in the circulation of counterfeit medicines through online channels, alongside growing reports of products being illicitly exported from Türkiye to foreign… »
Plant Protection Products: Digital Governance and Traceability
Plant protection products (“PPPs”) are defined in legislation in a broad and highly technical manner. They include preparations used to protect plants and plant products against harmful organisms or to prevent their effects, excluding products intended solely for plant nutrition. These products may also influence plant growth, control or prevent undesirable developments, or eliminate unwanted plants, and typically consist of one or more active ingredients that work… »
Food Supplements
Following the structural changes introduced in 2023 to the regulatory framework governing health claims on food and dietary supplements, the subsequent period has been characterised less by new legislative intervention and more by regulatory consolidation and practical implementation. The removal of mandatory prior administrative approval for health claims has remained in effect, reshaping the compliance landscape by shifting greater responsibility onto economic… »
Healthcare System Reforms
In July 2025, Türkiye introduced Law No. 7557, bringing wide-ranging updates to the healthcare system. These reforms aim to modernise services, improve efficiency, and strengthen oversight, responding to growing healthcare demands and technological developments. For the life sciences sector, several provisions are particularly relevant: Physicians and dentists are now limited to practicing in a maximum of two healthcare institutions, marking a shift toward tighter workforce… »
Medical Devices: New Sanctions and Technical Service Governance
Recent regulatory developments in the medical devices sector point to a shift from procedural compliance toward enforcement-driven market discipline, coupled with a gradual restructuring of technical service governance. A major inflection point in this trajectory was the entry into force of Law No. 7557 in July 2025, which introduced Additional Article 20 to the Basic Law on Health Services. This provision significantly expanded the administrative sanctions framework… »
Interactions with Healthcare Professionals, Transfer of Values and Conditions of Payment
Interactions between life sciences companies and healthcare professionals (“HCPs”) in Türkiye continue to be governed by a well-established regulatory framework. In the pharmaceutical sector, promotional activities remain subject to the Regulation on the Promotion of Medicinal Products for Human Use, which strictly limits promotion to healthcare professionals and prohibits direct or indirect advertising to the public. Engagements such as consultancy and service arrangements… »
Regulatory and Judicial Trends Shaping Access to NPP Products
NPPs operate as special import regimes that enable access to medicines that are either not authorised in Türkiye or are temporarily unavailable on the domestic market, upon the request of a treating physician. Fundamentally designed to address urgent or exceptional patient needs, the NPP framework has gradually evolved into a more structured and regulated supply mechanism. A significant step in this evolution was the entry into force of the Regulation on the Importation of… »
Market Access - Alternative Reimbursement Models
Alternative reimbursement models in Türkiye provide pathways for innovative medicines to gain coverage outside standard pricing rules, allowing the Social Security Institution (“SSI”) to negotiate terms such as discounts, budget caps, or other arrangements. These models, formalised under the 2016 Regulation on Alternative Reimbursement and updated in 2023, aim to improve patient access while managing healthcare expenditures. The Regulation on Alternative Reimbursement… »
GSK Succeeds in Bad Faith Case in Türkiye
This article examines a lawsuit concerning the use of a trademark, after it was registered in Türkiye by a third party, with the aim of threatening infringement proceedings against the company that is the rightful owner of the mark and evaluates how the courts protect the genuine rights holder against bad faith registration. Background The dispute concerned the bad faith registration of a trademark that had previously been registered in Türkiye in the name of Stiefel… »
Trademark Applications Made in Bad Faith and the Assessment of Bad Faith in EU Law under the CP13 Common Practice
In European Union (“EU”) legislation relating to trademark law, the concept of bad faith in trademark applications is not explicitly defined, nor are its boundaries clearly established. Although EU case-law provides significant guidance on the concept, it has been observed that there are different interpretations in practice and there are challenges in regard to achieving uniformity, making it difficult to foresee the manner in which assessment of claims of bad faith are… »
News and Events
Baran Güney, Dilan Sıla Kayalıca and Zeynep Çağla Üstün, are Listed as Rising Star by Euromoney's MIP IP STARS 2025
We are delighted to announce that Baran Güney, Dilan Sıla Kayalıca and Zeynep Çağla Üstün, managing associates in our intellectual property practice, have been recognized as Rising Stars in this year’s IP STARS ranking by Managing IP. Managing IP’s Rising Stars list, recognizes some of the best up-and-coming intellectual property practitioners in private practice who have contributed to the success of their firms and clients.
Baran Güney, Dilan Sıla Kayalıca and Zeynep Çağla Üstün, are Listed as Rising Star by Euromoney's MIP IP STARS 2024
We are delighted to announce that Baran Güney, Dilan Sıla Kayalıca and Zeynep Çağla Üstün, managing associates in our intellectual property practice, have been recognized as Rising Stars in this year’s IP STARS ranking by Managing IP. Managing IP’s Rising Stars list, recognizes some of the best up-and-coming intellectual property practitioners in private practice who have contributed to the success of their firms and clients.
Uğur Aktekin Will Speak at the AIDV Conference 2025 in Verona
We are pleased to announce Uğur Aktekin will be speaking in Verona at the 40th AIDV (IWLA – International Wine Law Association) Conference about Advertising & Marketing of Alcoholic Beverages on October 17, 2025. The International AIDV-IWLA Conference 2025 marks the 40th anniversary of the Association Internationale des Juristes du Droit de la Vigne et du Vin (AIDV). The event will bring together legal and industry experts from around the world to discuss key topics…
We are Attending the 2025 Trademark Administrators and Practitioners (TMAP) Meeting in Berlin
Gün + Partners is pleased to be attending the 2025 INTA Trademark Administrators and Practitioners (TMAP) Meeting in Berlin. Our firm will be represented by Canan Tınaz from our trademarks and designs practice. This year’s Meeting the largest European TMAP to date will bring together trademark professionals from across the globe. The program will address the latest developments in trademark law, brand protection, leadership, AI, European regulations, and more, while also…
Mutlu Yıldırım Köse and İrem Girenes Yücesoy Will Attend the MARQUES 39th Annual Conference in The Hague
We are excited to announce our participation in the 2025 MARQUES Annual Conference in The Hague and warmly invite you to meet with us during the event. Mutlu Yıldırım Köse and İrem Girenes Yücesoy will be representing Gün + Partners at the conference. This year's MARQUES Annual Conference sessions will focus on brand changes in an international context. Sessions will cover a wide range of topics including: the impact of external factors on IP work; brands in international…
Uğur Aktekin Will Speak at the 2025 Policy Dialogue: Strengthening Brands in Uzbekistan and Beyond
Uğur Aktekin will speak on “Recognizing and Promoting Well-Known Marks: Global Insights from INTA’s Famous and Well-Known Marks Committee” during 2025 Policy Dialogue: Strengthening Brands in Uzbekistan and Beyond event. This event is about practical strategies to combat counterfeit products in Uzbekistan and effective approaches to recognizing and promoting well-known marks in the region, bringing together brand owners, IP attorneys, and rights holders from across…
We are Attending the IBA Annual Conference 2025 in Toronto
We are excited to announce our participation in the International Bar Association (IBA) Annual Conference 2025 in Toronto and warmly invite you to meet with us during the event. Representing Gün + Partners at the conference will be Görkem Bilgin, Özge Atılgan Karakulak, Advisory Board Member of the IP and Entertainment Law Committee. As an independent law firm recognized internationally among the top-tier legal services providers, we pride ourselves on our strong global…
We Have Been Recognized in the WTR Global Leaders 2025
We are proud to announce that Mehmet Gün, Barış Kalaycı, Hande Hançar, Uğur Aktekin and Pınar Arıkan have been recognized in the WTR Global Leaders 2025. WTR Global Leaders evaluates law firms and corporate trademark experts according to their expertise and experience in relation to creating, protecting, managing and enforcing essential brand rights, and also their ability to innovate, inspire and go above and beyond to deliver for their clients.
Mehmet Gün Listed in IAM Strategy 300 2025
We’re proud to share that Mehmet Gün has been recognized in the IAM Strategy 300: The World’s Leading IP Strategists 2025. This prestigious list highlights individuals who are shaping the future of IP through innovative and high-impact portfolio strategies. The IAM Strategy 300 identifies global leaders who excel at developing and implementing approaches that unlock the full value of intellectual property.
Gün + Partners Top Ranked by IP STARS 2025
We are thrilled to announce that Gün + Partners has been top-ranked by Managing IP’s IP STARS 2025! Our team has been recognized as a top-tier practice for trade mark disputes, trade mark prosecution, and copyright & related rights. Four of our practitioners have been listed among the trade mark stars by IP STARS 2025. A special congratulations to Hande Hançar for being recognized among the Top 250 Women in IP in the 2025 edition. Our patent team has been recognized as…
Gün + Partners Top Ranked by IP STARS 2024
We are thrilled to announce that Gün + Partners has been top-ranked by Managing IP’s IP STARS 2024! Our team has been recognized as a top-tier practice for trade mark disputes, trade mark prosecution, and copyright & related rights. Four of our practitioners have been listed among the trade mark stars by IP STARS 2024. A special congratulations to Hande Hançar for being recognized among the Top 250 Women in IP in the 2024 edition. Our patent team has been recognized as…
Meet us at the 2025 AIPPI World Congress in Yokohama
Gün + Partners' AIPPI team is excited to attend the AIPPI World Congress in Yokohama this year. The AIPPI World Congress brings together professionals, experts, and stakeholders from around the world in the field of intellectual property (IP) to network, exchange knowledge, and foster business development. Representing Gün + Partners at the conference will be Aysel Korkmaz Yatkın (Partner in patents and utility models practice) and Zeynep Seda Alhas (Partner in trademarks…